1. India Stocks

  2. •

    Health technology

  3. •

    Medical specialties
Shree Pacetronix Limited

Shree Pacetronix Limited

BBSE:SHREEPAC
167.95
INR
+8.50
(+5.33%)
8.74EPS
14.71P/E
490.09MMarket Cap
Shree Pacetronix Limited
BSE:SHREEPAC
(Bombay Stock Exchange)

Recent

price

167.95

P/E

ratio

14.71

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
INR
15.93
19.54
18.08
21.28
18.35
20.68
19.29
18.9
20.23
24.35
21
25.64
56.27
61.23
46.68
59.6
58.19
Revenue per Share
-0.66
- -
0.47
0.64
-0.17
-0.24
-0.9
0.37
0.39
0.66
0.15
2.17
9.06
9.33
2.08
8.66
8.88
Basic EPS, GAAP
1.18
-1.1
1.06
1.68
-0.41
3.22
-1.46
1.74
-2.59
2.24
0.91
3.76
1.28
-0.04
-2.01
4.66
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
14.06
14.07
14.54
15.18
14.91
14.68
13.77
14.45
14.84
15.5
15.65
17.82
26.88
36.21
38.29
48.3
- -
Book Value per Share
11.16
11.47
12.39
13.36
13.55
13.77
13.33
14.16
14.57
15.24
15.4
17.57
26.64
35.97
38.06
47.83
- -
Tangible Book Value per Share
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
Basic Weighted Avg Shares
57
70
65
77
66
74
69
68
73
88
76
92
203
220
168
216
212
Sales/Revenue/Turnover
-2.39
5.41
10.18
10.51
4.05
4.11
-1.47
7.89
5.67
8.86
7.71
13.88
24.62
22.38
9.11
21.14
21.36
Operating Margin (%)
5
6
6
6
8
8
7
4
4
5
5
5
6
- -
8
7
7
Depreciation Expense
-2
- -
2
2
-1
-1
-3
1
1
2
1
8
33
34
7
31
32
Net Income, GAAP
- -
85.15
34.89
33.15
- -
- -
- -
30.24
44.44
32.89
59.82
26.37
29.45
27.35
28.1
25.39
25.39
Effective Tax Rate (%)
-4.14
0.02
2.62
3
-0.91
-1.15
-4.67
1.95
1.94
2.71
0.7
8.46
16.09
15.24
4.46
14.53
15.27
Profit Margin (%)
11
16
18
21
23
27
22
28
25
16
16
20
43
69
83
124
- -
Working Capital
8
5
3
1
2
2
5
9
12
6
7
6
4
5
4
3
- -
LT Debt
51
51
52
55
54
53
50
52
53
56
56
64
97
130
138
181
- -
Total Equity
- -
0.02
2.17
2.96
- -
- -
- -
4.42
3.43
5.11
1.93
9.9
29.09
21.97
5.72
16.63
- -
Return on Invested Capital (%)
- -
0.8
5.41
6.74
- -
- -
- -
4.23
3.52
5.28
2.1
10.76
32.22
24.82
6.46
17.39
- -
Return on Capital (%)
-4.57
0.03
3.31
4.29
-1.11
-1.6
-6.34
2.61
2.68
4.34
0.95
12.96
40.52
29.58
5.59
19.72
- -
Return on Common Equity (%)

Capital Structure

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
ST Debt
- -
24
- -
LT Borrowings
- -
3
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
4
4
4
Market Capitalization
697
343
490

Working Capital

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
Total Current Assets
- -
196
- -
Cash, Cash Equivalents & STI
- -
15
- -
Accounts Receivable, Net
- -
106
- -
Inventories
- -
48
- -
Total Current Liabilities
- -
72
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
24
- -
Deferred Revenue
- -
- -
- -

Growth Rates

INR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
14.34%
27.31%
31.4%
Free Cash Flow
397.98%
967.84%
-333.26%
Net Income, GAAP
206.85%
386.43%
319.22%
Sales/Revenue/Turnover
16.03%
31.07%
28.77%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
49
40
36
43
168
2026
53
66
43
54
216
2027
49
- -
- -
- -
- -

Quarterly Earnings Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
1.03
0.09
-0.31
1.26
2.08
2026
1.85
3.64
0.16
3.06
8.66
2027
2.02
- -
- -
- -
- -

Quarterly Dividends Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
2027
- -
- -
- -
- -
- -
Similar Companies
Intuitive Surgical, Inc. (NASDAQ:ISRG)
Boston Scientific Corporation (NYSE:BSX)
Thermo Fisher Scientific Inc (NYSE:TMO)
Illumina, Inc. (NASDAQ:ILMN)
Abbott Laboratories (NYSE:ABT)
GRAIL, Inc. (NASDAQ:GRAL)
Business
Shree Pacetronix Limited Shree Pacetronix Limited manufactures and sells implantable cardiac pacemakers and related medical devices through its subsidiary Shree Coratomic Limited, operating primarily in the cardiac rhythm management segment for healthcare providers and patients requiring anti-bradycardia treatments in India and internationally. The company produces a range of single and dual chamber pacemakers including models such as Ventralite 940+, Tiranga, Pinnacle-8820, Tiranga-302, Pinnacle-R-SSIR-Model-29, Trinity-R, Smart-E, Charak DDDR, and Indus I SSB; pacing leads encompassing Atrial J-Bipolar Lead-3851-VB, IS1 Bipolar Lead 3851 VB, Screw-in Lead P12, and Zeus-1; and pacing system analyzers featuring dual chamber models with operating modes like VVI, VOO, AAI, AOO, DOO, DDD, VDD, and DAI, supporting basic rates from 30 to 140 PPM, output amplitudes up to 12V, and sensitivity thresholds for atrium and ventricle. Incorporated on January 11, 1988, as a private limited company and converted to public limited status in 1993, Shree Pacetronix Limited is headquartered in Pithampur, Madhya Pradesh, India, and listed on the Bombay Stock Exchange with approximately 5500 shareholders. In recent developments, the company received INR 10.65 million in funding in November 2025 with participation from Akash Sethi acquiring a 7.71% equity stake; issued and allotted equity shares and warrants via preferential issue; reappointed Atul Kumar Sethi as Managing Director; and faces an open offer from Akash Sethi to acquire up to 975,000 shares representing 26% of expanded share capital at INR 100 per share, opening October 31, 2025, with the Independent Directors Committee deeming the price fair and reasonable as of October 2025.